Timeliness of intravenous thrombolysis via telestroke in Georgia

Stroke

Volumn 44, Issue 9, 2013, Pages 2620-2622

  Bruno, Askiel ^a   Lanning, Katherine M ^a   Gross, Hartmut ^a   Hess, David C ^a   Nichols, Fenwick T ^a   Switzer, Jeffrey A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Acute stroke; Intravenous tissue type plasminogen activator; Ischemic stroke; Stroke care; Telemedicine; Telestroke; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; EMERGENCY WARD; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PRIORITY JOURNAL; REGISTRATION; RETROSPECTIVE STUDY; TELECONSULTATION; TELEMEDICINE; TELESTROKE; UNITED STATES;

ACUTE STROKE; INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR; ISCHEMIC STROKE; STROKE CARE; TELEMEDICINE; TELESTROKE; THROMBOLYSIS;

ADULT; EMERGENCY MEDICAL SERVICES; GEORGIA; HUMANS; RETROSPECTIVE STUDIES; STROKE; TELEMEDICINE; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 84884500923     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001898     Document Type: Article

References (8)

1. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al.; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703.
2. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Hernandez AF, Peterson ED, et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke. 2011;42:2983-2989.
3. Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology. 2012;79:306-313.
4. Ford AL, Williams JA, Spencer M, McCammon C, Khoury N, Sampson TR, et al. Reducing door-to-needle times using Toyota's lean manufacturing principles and value stream analysis. Stroke. 2012;43:3395-3398.
5. Demaerschalk BM, Raman R, Ernstrom K, Meyer BC. Efficacy of telemedicine for stroke: pooled analysis of the Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC) and STRokE DOC Arizona telestroke trials. Telemed J E Health. 2012;18:230-237.
6. Schwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, et al.; American Heart Association Stroke Council; Interdisciplinary Council on Peripheral Vascular Disease. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2009;40:2616-2634.
7. Schwamm LH, Audebert HJ, Amarenco P, Chumbler NR, Frankel MR, George MG, et al.; American Heart Association Stroke Council; Council on Epidemiology and Prevention; Interdisciplinary Council on Peripheral Vascular Disease; Council on Cardiovascular Radiology and Intervention. Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke. 2009;40:2635-2660.
8. Adams RJ, Debenham E, Chalela J, Chimowitz M, Hays A, Hill C, et al. REACH MUSC: A Telemedicine Facilitated Network for Stroke: Initial Operational Experience. Front Neurol. 2012;3:33.